HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diclofenac sodium in the treatment of primary nocturnal enuresis: double-blind crossover study.

Abstract
The prostaglandin synthesis inhibitor diclofenac sodium has been compared with a placebo in the treatment of primary nocturnal enuresis in a double-blind crossover trial. Twenty patients were entered: 14 female, six male; age range 6-17 years. The results showed that diclofenac sodium was significantly more effective than placebo in the treatment of nocturnal enuresis.
AuthorsN S Al-Waili
JournalClinical and experimental pharmacology & physiology (Clin Exp Pharmacol Physiol) Vol. 13 Issue 2 Pg. 139-42 (Feb 1986) ISSN: 0305-1870 [Print] Australia
PMID3519020 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Prostaglandins
  • Diclofenac
Topics
  • Adolescent
  • Child
  • Clinical Trials as Topic
  • Diclofenac (therapeutic use)
  • Double-Blind Method
  • Enuresis (drug therapy, etiology, physiopathology)
  • Female
  • Humans
  • Male
  • Pressure
  • Prostaglandins (physiology)
  • Urethra (physiopathology)
  • Urinary Bladder (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: